Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-17-003847

President and CEO sold 3,000 shares at an average $9.50 ($28,485)

From the SEC's structured data for this filing

Trades in this filing

Leuthner Brian A · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-02-01 Sale : show line 1 in the form −1,500 $9.38 $14,070 251,479 D
2017-02-02 Sale : show line 2 in the form −1,500 $9.61 $14,415 249,979 D
Open-market sales · 3,000 sh · avg $9.50 · $28,485
Loading xslF345X03/form4.xml…